tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CNS Pharmaceuticals Increases Authorized Shares for Growth
PremiumCompany AnnouncementsCNS Pharmaceuticals Increases Authorized Shares for Growth
2M ago
CNS Pharmaceuticals: Promising Drug Pipeline and Strategic Plans Drive Buy Rating
Premium
Ratings
CNS Pharmaceuticals: Promising Drug Pipeline and Strategic Plans Drive Buy Rating
2M ago
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D
Premium
Company Announcements
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D
2M ago
CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year
PremiumThe FlyCNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year
6M ago
CNS Pharmaceuticals sees cash runway into 2H26
Premium
The Fly
CNS Pharmaceuticals sees cash runway into 2H26
6M ago
CNS Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
CNS Pharmaceuticals Reports Q2 2025 Financial Results
6M ago
CNS Pharmaceuticals Posts Investor Presentation on Brain Cancer
PremiumCompany AnnouncementsCNS Pharmaceuticals Posts Investor Presentation on Brain Cancer
7M ago
CNS Pharmaceuticals to present on TPI 287 at Brain Tumor Biotech Summit
Premium
The Fly
CNS Pharmaceuticals to present on TPI 287 at Brain Tumor Biotech Summit
8M ago
CNS Pharmaceuticals price target raised to $7 from $4 at Alliance Global Partners
Premium
The Fly
CNS Pharmaceuticals price target raised to $7 from $4 at Alliance Global Partners
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100